Keymed Biosciences, Inc.'s market cap is currently HK$20.69B. The company's EPS TTM is HK$-0.327949137; its P/E ratio is ―; Keymed Biosciences, Inc. is scheduled to report earnings on August 26, 2025, and the estimated EPS forecast is HK$―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 24
Dec 23
Dec 22
Dec 21
Dec 20
Currency in CNY
Keymed Biosciences, Inc. Earnings and Revenue History
